| Year |
Citation |
Score |
| 2020 |
Titone D, Mercier J, Sudarshan A, Pivneva I, Gullifer J, Baum S. Spoken word processing in bilingual older adults: Assessing within- and cross-language competition using the visual world task Linguistic Approaches to Bilingualism. DOI: 10.1075/Lab.18028.Tit |
0.32 |
|
| 2019 |
Ritchie EK, Latremouille-Viau D, Guerin A, Pivneva I, Habucky K, Ndife B, Joseph GJ, Atallah EL. Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective. Leukemia & Lymphoma. 1-9. PMID 30668234 DOI: 10.1080/10428194.2018.1538510 |
0.354 |
|
| 2019 |
Lin F, Kwong J, Ionescu-Ittu R, Pivneva I, Wynant W, Shi S, Wu EQ, Abraham JA. Work productivity loss in patients with tenosynovial giant cell tumors in the United States. Journal of Clinical Oncology. 37: e22527-e22527. DOI: 10.1200/Jco.2019.37.15_Suppl.E22527 |
0.301 |
|
| 2018 |
Dana R, Bradley JL, Guerin A, Pivneva I, Evans AM, Stillman IÖ. Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study. American Journal of Ophthalmology. PMID 30312577 DOI: 10.1016/J.Ajo.2018.10.001 |
0.301 |
|
| 2018 |
Seiter K, Latremouille-Viau D, Guerin A, Ndife B, Habucky K, Tang DH, Pivneva I, Gagnon-Sanschagrin P, Joseph GJ. Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States. Advances in Therapy. PMID 30155792 DOI: 10.1007/S12325-018-0772-3 |
0.312 |
|
| 2018 |
Borghaei H, Yim YM, Guerin A, Pivneva I, Shi S, Gandhi M, Ionescu-Ittu R. Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy. Lung Cancer (Amsterdam, Netherlands). 119: 112-119. PMID 29656745 DOI: 10.1016/J.Lungcan.2018.02.011 |
0.346 |
|
| 2018 |
Lin F, Ionescu-Ittu R, Pivneva I, Wynant W, Shi S, Shohudi Mojdehi A, Wu E, Kwong J, Abraham JA. Disability burden in patients with tenosynovial giant cell tumors in the United States from employer perspective. Journal of Clinical Oncology. 36: 92-92. DOI: 10.1200/Jco.2018.36.30_Suppl.92 |
0.302 |
|
| 2018 |
Ritchie EK, Sadek I, Pivneva I, Guerin A, Latremouille-Viau D, Ndife B, Joseph GJ, Atallah EL. Symptoms following TKI therapy discontinuation after achieving an adequate response in patients with chronic myeloid leukemia in chronic phase (CML-CP). Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E19024 |
0.319 |
|
| 2018 |
Seiter K, Latremouille-Viau D, Guerin A, Ndife B, Habucky K, Joseph G, Pivneva I, Gagnon-Sanschagrin P, Tang D. Comparison of Healthcare Resource Utilization (HRU) and Costs Related to Pleural Effusion (PE) Between Patients Newly Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Dasatinib or Nilotinib as First-Line Therapy in the United States Value in Health. 21. DOI: 10.1016/J.Jval.2018.04.176 |
0.321 |
|
| 2018 |
Ritchie EK, Sadek I, Pivneva I, Guerin A, Latremouille-Viau D, Ndife B, Joseph GJ, Atallah EL. Symptoms Following Discontinuation of Tyrosine Kinase Inhibitor (TKI) Therapy After Achieving an Adequate Response in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Clinical Lymphoma, Myeloma & Leukemia. 18. DOI: 10.1016/J.Clml.2018.07.091 |
0.309 |
|
| 2017 |
Ritchie EK, Wolff JE, Latremouille-Viau D, Guerin A, Pivneva I, Briggs O, Joseph GJ, Atallah EL. Tyrosine kinase inhibitor (TKI) therapy discontinuation in patients with CML in chronic phase: A US clinical practice perspective. Journal of Clinical Oncology. 35: 7052-7052. DOI: 10.1200/Jco.2017.35.15_Suppl.7052 |
0.302 |
|
| 2015 |
MERCIER J, PIVNEVA I, TITONE D. The role of prior language context on bilingual spoken word processing: Evidence from the visual world task* Bilingualism. DOI: 10.1017/S1366728914000340 |
0.309 |
|
| 2014 |
Pivneva I, Mercier J, Titone D. Executive control modulates cross-language lexical activation during L2 reading: evidence from eye movements. Journal of Experimental Psychology. Learning, Memory, and Cognition. 40: 787-96. PMID 24446754 DOI: 10.1037/A0035583 |
0.319 |
|
| 2014 |
Mercier J, Pivneva I, Titone D. Individual differences in inhibitory control relate to bilingual spoken word processing Bilingualism. 17: 89-117. DOI: 10.1017/S1366728913000084 |
0.311 |
|
| 2012 |
Pivneva I, Palmer C, Titone D. Inhibitory control and l2 proficiency modulate bilingual language production: evidence from spontaneous monologue and dialogue speech. Frontiers in Psychology. 3: 57. PMID 22438846 DOI: 10.3389/Fpsyg.2012.00057 |
0.306 |
|
| 2011 |
Pivneva I, Sudarshan A, Mercier J, Baum S, Titone D. Individual differences in executive function modulate bilingual between-language activation during reading in healthy older adults: Evidence from eye-tracking Procedia - Social and Behavioral Sciences. 23: 35-36. DOI: 10.1016/J.Sbspro.2011.09.157 |
0.301 |
|
| Show low-probability matches. |